slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 203,941-203,970
Pages 10,126
Rows per page 30
Component
203,941-203,970 of 303,780
07
Includes year-on-year growth percentages for active consumers.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
The slide uses a dual-bar chart structure to compare Orders and GTV, with annotations for YoY growth and CAGR.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The slide uses a dual-metric bar chart approach with YoY growth and CAGR indicators.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
The slide provides a clear bridge between past performance and future expectations, highlighting the update to 2022 guidance while maintaining long-term targets.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide uses a combination of a line chart for Gross Profit Margin and a bar chart for Adjusted EBITDA Margin, with a forward-looking 'implied' projection for H2 2022.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Deliveroo corporate presentation slide.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · Action1 hit
14
Deliveroo | Results Presentation Deck | 16 slidesDeliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations 1 hit
15
Data is segmented by region and includes year-over-year growth percentages and margins as a percentage of GTV.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations 1 hit
16
Deliveroo | Results Presentation Deck | 16 slidesDeliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations 1 hit
01
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
02
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
03
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
04
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
05
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
06
The slide uses a chevron-based table structure to link disease states to market validation.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Market Size1 hit
07
The diagram uses a branching logic to show how core pipelines lead to multiple indications/products, which then feed into a value-maximization arrow.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
08
The slide uses a Gantt-style visualization to show progress of drug candidates.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
09
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Team1 hit
10
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Team1 hit
11
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Team1 hit
12
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
13
The slide uses a biological process diagram to illustrate the mechanism of immune cell activation.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a visual metaphor to explain immune evasion.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
The slide uses a visual metaphor of a dendritic cell connecting to a stacked list of therapeutic outcomes.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a process flow framework to explain the production of an off-the-shelf cell therapy.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide presents visual evidence (photos of tumors) alongside quantitative bar charts showing efficacy metrics.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a ribbon-style process diagram to show progression from proof-of-concept to clinical trials.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
20
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
21
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit